ArticlePDF Available

The Importance of Halotherapy in the Treatment of COVID-19 Related Diseases

DOI:10.29333/jcei/8486
Authors:
Burhanettin Uysal at Bilecik Şeyh Edebali University
Burhanettin Uysal
  • Bilecik Şeyh Edebali University
Ebrar Ulusinan Çubukçu at Bilecik Şeyh Edebali Üniversitesi
Ebrar Ulusinan Çubukçu
  • Bilecik Şeyh Edebali Üniversitesi
Download full-text PDF
Read full-text
Download citation

Abstract

Treatment and post-treatment rehabilitation of COVID-19, which first appeared in Wuhan, China at the end of 2019, causing hundreds of thousands of people to die, has become very important for both patients and scientists. Some chronic health problems, especially in healing patients, have led to the emergence of alternative treatment methods. Significant studies have been conducted on COVID-19 triggering chronic respiratory diseases in patients recovered because of the effects on the respiratory tract. In some studies, it was found that individuals who recovered could not use the functions of the lung with their pre-disease capacity. Halotherapy, which is a treatment method applying by be delivered a fine powder to the upper part of the lower respiratory tract of a person, is a natural and reliable therapy method for respiratory infections, asthma, allergic and chronic bronchitis, colds, pharyngitis, rhinitis, tonsillitis, chronic obstructive pulmonary disease, and various skin diseases. Halotherapy has an important place in alternative medicine. Many studies have been carried out on the benefit of Halotherapy, which is considered both Salt Therapy and Cave Therapy, in chronic respiratory diseases. In this context, it is considered that Halotherapy can be useful in the treatment of chronic respiratory diseases of individuals with COVID-19 disease in our study based on these studies. Also, scientific studies are recommended treating patients with COVID-19 in areas where salt therapy and speleotherapy are involved in the treatment of chronic respiratory diseases.
Content uploaded by Burhanettin Uysal
Author content
All content in this area was uploaded by Burhanettin Uysal on Aug 29, 2020
Content may be subject to copyright.
Volume 11 • Number 4 • December 2020 • em00754
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 1 / 7
RESEARCH ARTICLE
Treatment and post-treatment rehabilitation of COVID-19, which first appeared in Wuhan,
China at the end of 2019, causing hundreds of thousands of people to die, has become very
important for both patients and scientists. Some chronic health problems, especially in healing
patients, have led to the emergence of alternative treatment methods. Significant studies have
been conducted on COVID-19 triggering chronic respiratory diseases in patients recovered
because of the effects on the respiratory tract. In some studies, it was found that individuals
who recovered could not use the functions of the lung with their pre-disease capacity.
Halotherapy, which is a treatment method applying by be delivered a fine powder to the upper
part of the lower respiratory tract of a person, is a natural and reliable therapy method for
respiratory infections, asthma, allergic and chronic bronchitis, colds, pharyngitis, rhinitis,
tonsillitis, chronic obstructive pulmonary disease, and various skin diseases. Halotherapy has
an important place in alternative medicine. Many studies have been carried out on the benefit
of Halotherapy, which is considered both Salt Therapy and Cave Therapy, in chronic respiratory
diseases. In this context, it is considered that Halotherapy can be useful in the treatment of
chronic respiratory diseases of individuals with COVID-19 disease in our study based on these
studies. Also, scientific studies are recommended treating patients with COVID-19 in areas
where salt therapy and speleotherapy are involved in the treatment of chronic respiratory
diseases.
Keywords: COVID-19, halotherapy, respiratory diseases
Halotherapy in the Treatment of COVID-19
2 / 7 | Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. www.jceionline.org
Figure 1. Types of Halotherapy
Halotherapy in the Treatment of COVID-19
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 3 / 7
Halotherapy in the Treatment of COVID-19
4 / 7 | Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. www.jceionline.org
Halotherapy in the Treatment of COVID-19
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 5 / 7
Halotherapy in the Treatment of COVID-19
6 / 7 | Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. www.jceionline.org
Halotherapy in the Treatment of COVID-19
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 7 / 7
... In the field of alternative medicine, halotherapy plays a significant role. The healing effects of halotherapy, also known as salt therapy and cave therapy, have been the subject of numerous scientific investigations (3) In recent decades, halotherapy has gained the attention of an increasing number of people worldwide and is spreading rapidly in Western Europe, Japan, Israel, North America, and numerous other nations. Numerous studies demonstrating its efficacy and applicability in treating various diseases have been published. ...
HALOTHERAPY IN THE TREATMENT OF SKIN DISEASES
Article
Full-text available
  • Jun 2023
Salt has been utilized for countless years in different regions worldwide for its health-promoting and therapeutic properties. Halotherapy is a dry salt therapy administered in settings with specialized equipment known as a halogenerator. In recent decades, halotherapy has gained the trust of an increasing number of people worldwide and spread rapidly throughout many countries. The positive effects of the treatment last longer than one year. Drug-free treatments for dermatoses and skin rejuvenation are gaining popularity in the health and beauty industry. Rehabilitative dermatology, cosmetic surgery, anti-ageing procedures, and detoxification regimens all use these techniques. Skin diseases are a significant public health issue that affects a large number of people all over the world. Halotherapy is the treatment of choice for some skin diseases due to the potential for combining it with additional physical forms of therapy as well as pharmacological therapies. The treatment’s minimal negative effects, combined with its delivery in a soothing setting, are beneficial to the mental and emotional health of both adults and kids. The re-profiling of post-mining areas benefits greatly from the growth of different kinds of mining tourism, including medical tourism. Even in today’s salt mining, which frequently combines conventional rock salt extraction with public access to the mine, these types of facilities remain popular. Halotherapy shows promise in treating a wide range of skin conditions thanks to the dry sodium chloride aerosol’s adaptable physiological effect. The healing and cosmetic effects of halotherapy on the skin have been confirmed by scientific studies, but despite the incontestable advantages of halotherapy, additional and more in-depth research on the curative effects of salt on a variety of skin conditions is currently required. The halocomplex serves as the foundation for this technological platform.This article aims to demonstrate the advantages of halotherapy as a complementary therapy for certain skin diseases and discusses the distinction between halotherapy and salt therapy, the technology behind halotherapy, the different application methods, its health benefits in dermatology, the most common indications for using halotherapy in skin treatment and cosmetology programs, the most common skin diseases that it can be used to treat, certain contraindications, as well as the possible negative effects of using halotherapy.
View
Recent Trends in Synthetic Strategies Using Magnetic Nanostructures as Green Catalysts in Synthesis of Pyran Analogues
Article
Full-text available
In recent years, magnetic nanoparticles and nanocomposites play an important role as a nanocatalyst in the creation of a wide range of bioactive heterocycles with extraordinarily high activity and selectivity, low energy consumption, and extended life. Among all heterocycles, many natural products, pharmaceuticals, and bioactive compounds contain pyran scaffolds which have a wide range of uses in biomedical research, industry, and medicine. Additionally, these are also widely used in the synthesis of novel heterocyclic systems as precursors. This study focused on recent advances in the last five years in the use of various magnetic recoverable and recycled nanoparticles and nanocomposites to synthesize pyran derivatives along with their pharmacological activity. This article has been classified into three subsections: (i) MNPs‐Metal Nanocomposite catalyzed reactions, (ii) MNPs‐Organic Based Nanocomposite catalyzed reactions, and (iii) MNPs‐Ionic Liquid Nanocomposite catalyzed reactions (iv) MNPs‐Acid Based Nanocomposite to describe catalytic efficiency of magnetic nanocomposites for the synthesis of pyran derivatives. A comparative study of nanocomposites and different approaches for green synthesis of pyrans by highlighting the advantages and disadvantages along with catalyst recovery and recyclability has been mentioned, which will help scientists to probe and stimulate the study of these scaffolds.
View
Silver nanoparticles (Ag NPs) as catalyst in chemical reactions
Article
  • Mar 2021
Catalysis is becoming a strategic area of science because it represents a new way to meet the challenges of energy and sustain ability. In recent times, silver nanoparticles (Ag NPs) were widely utilized as catalyst in a diverse range of organic transformations such as coupling, reduction and multicomponent reactions. In this review, we present recent developments in the catalytic application of silver nanoparticles (Ag NPs) in chemical reactions.
View
Recent reports on magnetic nanoparticles supported metallic catalysts: Synthesis of heterocycles
Article
  • Feb 2021
Heterocycles are an integral and important component in the structure of most drugs, natural products and biologically active compounds. Research on transition metal catalysts has recently received a lot of attention due to their unique properties. In recent times, the immobilization of metallic complexes on magnetic nanoparticles has presented as an interesting and efficient catalytic strategy for the synthesis of heterocyclic molecules. In this review, we focused on the constructions of metallic complexes immobilized on magnetic nanoparticles and investigated their catalytic activity in the synthesis of a library of heterocyclic compounds.
View
View
Magnetic nanotechnology: Catalysis in synthesis of pyran scaffolds
Article
  • Dec 2020
The pyran scaffolds are present in many natural products, pharmaceutical and bioactive molecules. These valuable bioactivities have prompted synthetic chemists to develop novel, green and efficient catalytic systems for the synthesis of pyran scaffolds. Nowadays, magnetic nanocatalysts have opened up new chapters for generating numerous products with extremely high activity and selectivity, low energy consumption and long life time. The present review summarizes the application of magnetic nanomaterials as efficient magnetically recoverable nanocatalysts for the synthesis of diverse biologically relevant pyran scaffolds reported so far.
View
View
Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
Article
Full-text available
  • Mar 2020
In late December 2019, a cluster of cases with 2019 Novel Coronavirus pneumonia (SARS-CoV-2) in Wuhan, China, aroused worldwide concern. Previous studies have reported epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19). The purpose of this brief review is to summarize those published studies as of late February 2020 on the clinical features, symptoms, complications, and treatments of COVID-19 and help provide guidance for frontline medical staff in the clinical management of this outbreak.
View
View
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Article
Full-text available
  • Feb 2020
Background Chest CT is used to assess the severity of lung involvement in COVID-19 pneumonia. Purpose To determine the change in chest CT findings associated with COVID-19 pneumonia from initial diagnosis until patient recovery. Materials and Methods This retrospective review included patients with RT-PCR confirmed COVID-19 infection presenting between 12 January 2020 to 6 February 2020. Patients with severe respiratory distress and/ or oxygen requirement at any time during the disease course were excluded. Repeat Chest CT was obtained at approximately 4 day intervals. The total CT score was the sum of lung involvement (5 lobes, score 1-5 for each lobe, range, 0 none, 25 maximum) was determined. Results Twenty one patients (6 males and 15 females, age 25-63 years) with confirmed COVID-19 pneumonia were evaluated. These patients under went a total of 82 pulmonary CT scans with a mean interval of 4±1 days (range: 1-8 days). All patients were discharged after a mean hospitalized period of 17±4 days (range: 11-26 days). Maximum lung involved peaked at approximately 10 days (with the calculated total CT score of 6) from the onset of initial symptoms (R2=0.25), p<0.001). Based on quartiles of patients from day 0 to day 26 involvement, 4 stages of lung CT were defined: Stage 1 (0-4 days): ground glass opacities (GGO) in 18/24 (75%) patients with the total CT score of 2±2; (2)Stage-2 (5-8d days): increased crazy-paving pattern 9/17 patients (53%) with a increase in total CT score (6±4, p=0.002); (3) Stage-3 (9-13days): consolidation 19/21 (91%) patients with the peak of total CT score (7±4); (4) Stage-4 (≥14 days): gradual resolution of consolidation 15/20 (75%) patients with a decreased total CT score (6±4) without crazy-paving pattern. Conclusion In patients recovering from COVID-19 pneumonia (without severe respiratory distress during the disease course), lung abnormalities on chest CT showed greatest severity approximately 10 days after initial onset of symptoms.
View
The Covid‐19 epidemic
Article
Full-text available
  • Feb 2020
The current outbreak of the novel coronavirus Covid‐19 (coronavirus disease 2019; previously 2019‐nCoV), epi‐centered in Hubei Province of the People's Republic of China, has spread to many other countries. On January 30, 2020, the WHO Emergency Committee declared a global health emergency based on growing case notification rates at Chinese and international locations. The case detection rate is changing hourly and daily and can be tracked in almost real time on website provided by Johns Hopkins University [1] and other websites. As of early February 2020, China bears the large burden of morbidity and mortality, whereas the incidence in other Asian countries, in Europe and North America remains low so far.
View
Clinical characteristics of 2019 novel coronavirus infection in China
Preprint
Full-text available
  • Feb 2020
Background: Since December 2019, acute respiratory disease (ARD) due to 2019 novel coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We sought to delineate the clinical characteristics of these cases. Methods: We extracted the data on 1,099 patients with laboratory-confirmed 2019-nCoV ARD from 552 hospitals in 31 provinces/provincial municipalities through January 29th, 2020. Results: The median age was 47.0 years, and 41.90% were females. Only 1.18% of patients had a direct contact with wildlife, whereas 31.30% had been to Wuhan and 71.80% had contacted with people from Wuhan. Fever (87.9%) and cough (67.7%) were the most common symptoms. Diarrhea is uncommon. The median incubation period was 3.0 days (range, 0 to 24.0 days). On admission, ground-glass opacity was the typical radiological finding on chest computed tomography (50.00%). Significantly more severe cases were diagnosed by symptoms plus reverse-transcriptase polymerase-chain-reaction without abnormal radiological findings than non-severe cases (23.87% vs. 5.20%, P<0.001). Lymphopenia was observed in 82.1% of patients. 55 patients (5.00%) were admitted to intensive care unit and 15 (1.36%) succumbed. Severe pneumonia was independently associated with either the admission to intensive care unit, mechanical ventilation, or death in multivariate competing-risk model (sub-distribution hazards ratio, 9.80; 95% confidence interval, 4.06 to 23.67). Conclusions: The 2019-nCoV epidemic spreads rapidly by human-to-human transmission. Normal radiologic findings are present among some patients with 2019-nCoV infection. The disease severity (including oxygen saturation, respiratory rate, blood leukocyte/lymphocyte count and chest X-ray/CT manifestations) predict poor clinical outcomes.
View
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic
Article
  • Mar 2020
In the event of a global infectious pandemic, drastic measures may be needed that limit or require adjustment of ambulatory allergy services. However, no rationale for how to prioritize service shut down and patient care exists. A consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily triage allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted modified Delphi methodology to achieve consensus. During the ongoing pandemic while social distancing is being encouraged, most allergy/immunology care could be postponed/delayed or handled through virtual care. With the exception of many patients with primary immunodeficiency, patients on venom immunotherapy, and patients with asthma of a certain severity, there is limited need for face-to-face visits under such conditions. These suggestions are intended to help provide a logical approach to quickly adjust service to mitigate risk to both medical staff and patients. Importantly, individual community circumstances may be unique and require contextual consideration. The decision to enact any of these measures rests with the judgment of each clinician and individual health care system. Pandemics are unanticipated, and enforced social distancing/quarantining is highly unusual. This expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.
View
View
View
View